B-Cancer	0	6	Cancer	Cancer	NN	B-NP
O	7	17	metastasis	metastasis	NN	I-NP
O	17	18	:	:	:	O
O	19	27	negative	negative	JJ	B-NP
O	28	38	regulation	regulation	NN	I-NP
O	39	41	by	by	IN	B-PP
O	42	44	an	an	DT	B-NP
O	45	53	invasion	invasion	NN	I-NP
O	53	54	-	-	HYPH	I-NP
O	54	64	suppressor	suppressor	NN	I-NP
O	65	72	complex	complex	NN	I-NP
O	72	73	.	.	.	O

O	75	83	Invasion	Invasion	NN	B-NP
O	84	86	is	be	VBZ	B-VP
O	87	90	the	the	DT	B-NP
O	91	99	hallmark	hallmark	NN	I-NP
O	100	102	of	of	IN	B-PP
B-Cancer	103	108	tumor	tumor	NN	B-NP
O	109	119	malignancy	malignancy	NN	I-NP
O	119	120	.	.	.	O

O	121	123	We	We	PRP	B-NP
O	124	131	situate	situate	VBP	B-VP
O	132	140	invasion	invasion	NN	B-NP
O	141	147	within	within	IN	B-PP
O	148	163	microecosystems	microecosystem	NNS	B-NP
O	164	174	comprising	comprise	VBG	B-VP
B-Cell	175	185	neoplastic	neoplastic	JJ	B-NP
I-Cell	186	191	cells	cell	NNS	I-NP
O	192	194	as	as	RB	B-CONJP
O	195	199	well	well	RB	I-CONJP
O	200	202	as	as	IN	I-CONJP
O	203	207	host	host	NN	B-NP
B-Cell	208	213	cells	cell	NNS	I-NP
O	213	214	.	.	.	O

O	215	225	Modulation	Modulation	NN	B-NP
O	226	228	of	of	IN	B-PP
O	229	237	invasion	invasion	NN	B-NP
O	238	244	within	within	IN	B-PP
O	245	249	such	such	JJ	B-NP
O	250	257	systems	system	NNS	I-NP
O	258	260	is	be	VBZ	B-VP
O	261	269	ascribed	ascribe	VBN	I-VP
O	270	272	to	to	TO	B-PP
O	273	281	balances	balance	NNS	B-NP
O	282	289	between	between	IN	B-PP
O	290	298	promoter	promoter	NN	B-NP
O	299	302	and	and	CC	I-NP
O	303	313	suppressor	suppressor	NN	I-NP
O	314	322	pathways	pathway	NNS	I-NP
O	322	323	.	.	.	O

O	324	327	The	The	DT	B-NP
O	328	329	E	E	NN	I-NP
O	329	330	-	-	HYPH	I-NP
O	330	338	cadherin	cadherin	NN	I-NP
O	338	339	/	/	SYM	B-NP
O	339	344	alpha	alpha	SYM	B-VP
O	344	345	-	-	HYPH	O
O	345	346	,	,	,	O
O	347	351	beta	beta	SYM	B-NP
O	351	352	-	-	HYPH	B-ADJP
O	352	353	,	,	,	O
O	354	359	gamma	gamma	SYM	B-NP
O	359	360	-	-	HYPH	B-NP
O	360	367	catenin	catenin	NN	I-NP
O	368	375	complex	complex	NN	I-NP
O	376	379	has	have	VBZ	B-VP
O	380	382	an	an	DT	B-NP
O	383	391	invasion	invasion	NN	I-NP
O	391	392	-	-	HYPH	I-NP
O	392	402	suppressor	suppressor	NN	I-NP
O	403	411	function	function	NN	I-NP
O	412	414	as	as	IN	B-SBAR
O	415	424	evidenced	evidence	VBN	B-VP
O	425	427	by	by	IN	B-PP
O	428	441	transfections	transfection	NNS	B-NP
O	442	448	either	either	CC	B-PP
O	449	453	with	with	IN	I-PP
O	454	459	sense	sense	NN	B-NP
O	460	464	cDNA	cDNA	NN	I-NP
O	465	473	encoding	encode	VBG	B-VP
O	474	479	these	these	DT	B-NP
O	480	489	molecules	molecule	NNS	I-NP
O	490	492	or	or	CC	B-PP
O	493	497	with	with	IN	B-PP
O	498	507	antisense	antisense	JJ	B-NP
O	508	512	cDNA	cDNA	NN	I-NP
O	513	523	inhibiting	inhibit	VBG	B-VP
O	524	529	their	their	PRP$	B-NP
O	530	540	expression	expression	NN	I-NP
O	540	541	.	.	.	O

O	542	546	Loss	Loss	NN	B-NP
O	547	549	of	of	IN	B-PP
O	550	564	heterozygosity	heterozygosity	NN	B-NP
O	565	567	at	at	IN	B-PP
O	568	571	the	the	DT	B-NP
O	572	573	E	E	NN	I-NP
O	573	574	-	-	HYPH	B-NP
O	574	582	Cadherin	Cadherin	NN	I-NP
O	583	584	(	(	(	O
O	584	587	uvo	uvo	NN	B-NP
O	587	588	)	)	)	O
O	589	594	locus	locus	NN	B-NP
O	595	598	has	have	VBZ	B-VP
O	599	603	been	be	VBN	I-VP
O	604	612	reported	report	VBN	I-VP
O	612	613	,	,	,	O
O	614	617	but	but	CC	O
O	618	627	mutations	mutation	NNS	B-NP
O	628	630	in	in	IN	B-PP
O	631	634	the	the	DT	B-NP
O	635	636	E	E	NN	I-NP
O	636	637	-	-	HYPH	B-NP
O	637	645	cadherin	cadherin	NN	I-NP
O	646	650	gene	gene	NN	I-NP
O	651	655	seem	seem	VBP	B-VP
O	656	658	to	to	TO	I-VP
O	659	661	be	be	VB	I-VP
O	662	666	rare	rare	JJ	B-ADJP
O	666	667	.	.	.	O

O	668	682	Downregulation	Downregulation	NN	B-NP
O	683	685	of	of	IN	B-PP
O	686	687	E	E	NN	B-NP
O	687	688	-	-	HYPH	B-NP
O	688	696	cadherin	cadherin	NN	I-NP
O	697	705	occurred	occur	VBD	B-VP
O	706	708	at	at	IN	B-PP
O	709	712	the	the	DT	B-NP
O	713	718	level	level	NN	I-NP
O	719	721	of	of	IN	B-PP
O	722	735	transcription	transcription	NN	B-NP
O	736	738	or	or	CC	B-PP
O	739	741	of	of	IN	B-PP
O	742	746	mRNA	mRNA	NN	B-NP
O	747	756	stability	stability	NN	I-NP
O	756	757	.	.	.	O

O	758	760	Ex	Ex	FW	B-NP
O	761	765	vivo	vivo	FW	I-NP
B-Cell	766	774	cultures	culture	NNS	I-NP
O	775	779	from	from	IN	B-PP
B-Cancer	780	788	invasive	invasive	JJ	B-NP
I-Cancer	789	795	tumors	tumor	NNS	I-NP
O	796	798	or	or	CC	I-NP
B-Cancer	799	809	metastases	metastasis	NNS	I-NP
O	810	818	produced	produce	VBD	B-VP
B-Cell	819	824	cells	cell	NNS	B-NP
O	825	829	that	that	WDT	B-NP
O	830	834	were	be	VBD	B-VP
O	835	848	homogeneously	homogeneously	RB	B-ADVP
O	849	850	E	E	NN	B-NP
O	850	851	-	-	HYPH	I-NP
O	851	859	cadherin	cadherin	NN	I-NP
O	859	860	-	-	HYPH	I-NP
O	860	868	positive	positive	JJ	I-NP
O	869	872	and	and	CC	I-NP
O	873	884	noninvasive	noninvasive	JJ	I-NP
O	885	887	in	in	FW	I-NP
O	888	893	vitro	vitro	FW	I-NP
O	893	894	.	.	.	O

O	895	900	These	These	DT	B-NP
O	901	913	observations	observation	NNS	I-NP
O	914	918	have	have	VBP	B-VP
O	919	922	led	lead	VBN	I-VP
O	923	925	to	to	TO	B-PP
O	926	929	the	the	DT	B-NP
O	930	934	idea	idea	NN	I-NP
O	935	939	that	that	IN	B-SBAR
O	940	947	factors	factor	NNS	B-NP
O	948	950	in	in	IN	B-PP
O	951	954	the	the	DT	B-NP
O	955	959	host	host	NN	I-NP
O	960	972	downmodulate	downmodulate	VBP	B-VP
O	973	976	the	the	DT	B-NP
O	977	978	E	E	NN	I-NP
O	978	979	-	-	HYPH	B-NP
O	979	987	cadherin	cadherin	NN	I-NP
O	988	995	complex	complex	NN	I-NP
O	996	999	and	and	CC	O
O	1000	1007	promote	promote	VB	B-VP
O	1008	1016	invasion	invasion	NN	B-NP
O	1017	1021	most	most	RBS	B-ADVP
O	1022	1030	probably	probably	RB	I-ADVP
O	1031	1033	in	in	IN	B-PP
O	1034	1035	a	a	DT	B-NP
O	1036	1045	transient	transient	JJ	I-NP
O	1046	1049	way	way	NN	I-NP
O	1049	1050	.	.	.	O

